Zelniker, Thomas A <br/><br/>
Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus.  [electronic resource] 

 -  Circulation  04 2019 
 - 2022-2031 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/CIRCULATIONAHA.118.038868  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Atherosclerosis--prevention & control<br/>Cardiovascular Diseases--prevention & control<br/>Clinical Trials as Topic<br/>Diabetes Mellitus, Type 2--complications<br/>Diabetic Cardiomyopathies--etiology<br/>Diabetic Nephropathies--etiology<br/>Female<br/>Glucagon-Like Peptide Receptors--agonists<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Kidney Diseases--prevention & control<br/>Male<br/>Middle Aged<br/>Proportional Hazards Models<br/>Sodium-Glucose Transporter 2 Inhibitors--pharmacology